MRNA
NASDAQStockModerna, Inc.
$52.56-1.01 (-1.89%)
52-Week Range
$22.36
$57.80
Key Stats
Market Cap
20.8B
P/E Ratio
—
Dividend Yield
—
Beta
1.35
Volume
4.9M
Avg Volume
12.0M
Performance
1M
+26.43%
3M
+78.44%
6M
+114.94%
YTD
+73.01%
1Y
+53.82%
3Y
-64.82%
5Y
-65.78%
Price Chart
ETF Exposure
MRNA is held by 326 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| WLDD.L | Amundi MSCI World Swap II UCITS ETF Dist | 0.01% |
| WLDL.L | Amundi MSCI World Swap II UCITS ETF Dist | 0.01% |
| WLDU.L | Amundi MSCI World Swap II UCITS ETF USD Hedged Dist | 0.01% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.01% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.00% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.00% |
| MMTM | State Street SPDR S&P 1500 Momentum Tilt ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| XCHG | Alliance Bernstein - AB US Equity ETF | 0.00% |
| DFLV | Dimensional - US Large Cap Value ETF | 0.00% |
| CHEP | AGFiQ U.S. Market Neutral Value Fund | 0.00% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 0.00% |
| LRND | NYLI U.S. Large Cap R&D Leaders ETF | 0.00% |
PreviousPage 7 of 7
About MRNA ETF Exposure
Moderna, Inc. (MRNA) is held by 326 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 20.8B, MRNA is a widely held institutional stock. The stock currently trades at $52.56. Investors can gain exposure to MRNA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MRNA, sorted by portfolio weight.